8-K ·Filed Apr 10, 2026

PHGE

BiomX Inc.
BULLISH
Impact 7/10
Horizonweeks Processed5mo ago SEC0001213900-26-042200
Killer combo: Material agreement + unregistered equity (likely PIPE/convertible)
Actionable Insight ▲ Bullish

The acquisition immediately expands BiomX into the defense AI sector with a revenue-generating asset. Traders should monitor the future earnout payment as a key performance indicator and watch for the upcoming registration statement filing within 45 days. The significant insider selling in the past 30 days ($13.3M) suggests caution despite the bullish transaction.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
PHGE ▼ -89.58% at T+60d
LONG call ✗ call lost -89.58% · α vs SPY -99.91% · entry $2.89 → $0.3010
Entry anchored
Apr 9, 02:20 PM ET
via exchange tick
T+1d
-9.00%
call -9.00% · α -9.97%
$2.63
settled 6mo ago
T+5d
-36.33%
call -36.33% · α -40.84%
$1.84
settled 6mo ago
T+20d
-78.58%
call -78.58% · α -87.11%
$0.6190
settled 5mo ago
T+60d
-89.58%
call -89.58% · α -99.91%
$0.3010
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

BiomX Inc. completed the acquisition of ZorroNet, an AI-powered defense technology company, using a combination of stock and a short-term promissory note. The deal expands BiomX into the defense and security sector with revenue-generating, deployed technology. The transaction includes a performance-based earnout and key employee retention provisions.

Key Financial Metrics

Deal Value
$1.3M
Deal Type
acquisition

Key Facts

  • BiomX acquired 100% of ZorroNet from Water IO Ltd.
  • Total consideration: 1,300,000 shares of PHGE stock and a $1.25M non-convertible promissory note due in 3 months.
  • Assumed obligations include a performance-based earnout payable by March 31, 2027, equal to the greater of 125% of ZorroNet's 2026 revenue or 8x EBITDA.
  • ZorroNet is a revenue-generating company with technology deployed at Israel Defense Forces bases and critical infrastructure.
  • BiomX will file a registration statement within 45 days to cover resale of the issued shares.

Financial Impact

The acquisition is valued at approximately $1.25M in cash plus stock. The future earnout is performance-based with a minimum value of 125% of 2026 revenue or 8x EBITDA.

dilutiondebtrevenueearnings

Risk Factors

  • The $1.25M note is due in 3 months and could strain liquidity if not refinanced.
  • The earnout payment is contingent on ZorroNet's 2026 financial performance.
  • Recent insider selling ($13.3M in 30 days) may indicate lack of confidence.
  • Integration risk of a new defense technology business into a biological products company.

Market Snapshot

Exchange
NYSE
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001213900-26-042200
Document: ea0285346-8k_biomx.htm0001213900-26-042200
Document: ea028534601ex99-1.htm0001213900-26-042200
Document: ea028534601ex4-1.htm0001213900-26-042200
Document: 0001213900-26-042200-index-headers.html0001213900-26-042200
Document: 0001213900-26-042200-index.html0001213900-26-042200
Document: 0001213900-26-042200.txt0001213900-26-042200
20 reports for PHGE
Performance horizon
70% Hit rate 7 of 10 directional calls best @ T+20▲ +62.36%Jun 16, 2026
Filters
Rows
Reports for PHGE — sortable, filterable
TypeNow
Sep 1, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$0.1425 $1.85▲ +1198.25%▲ +1199.20%$0.3600 (+152.63%)
Aug 28, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$0.1371 $0.1550▲ +13.06%▲ +13.20%$0.3600 (+162.58%)
Aug 5, 2026
8w ago
Press Release
BEARISH ★ 5/10
$0.1800 $0.1483▲ +17.61%▲ +17.96%$0.3600 (−100.00%)
Jul 28, 2026
9w ago
8-K
BEARISH ★ 8/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 28, 2026
9w ago
Press Release
BEARISH ★ 7/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 27, 2026
9w ago
424B5
BEARISH ★ 7/10
$0.1834 $0.1868▼ −1.85%▲ +0.42%$0.3600 (−96.29%)
Jul 8, 2026
12w ago
Press Release
NEUTRAL ★ 4/10
$0.2758 $0.2100▼ −23.86%▼ −24.72%$0.3600 (+30.53%)
Jul 2, 2026
13w ago
8-K
BEARISH ★ 6/10
$0.3190 $0.2800▲ +12.23%▲ +13.16%$0.3600 (−12.85%)
Jun 29, 2026
13w ago
S-1
BEARISH ★ 5/10
$0.3478 $0.3020▲ +13.17%▲ +13.77%$0.3600 (−3.51%)
Jun 22, 2026
14w ago
DEFA14A
NEUTRAL ★ 2/10
$0.4615 $0.3590▼ −22.21%▼ −23.22%$0.3600 (−21.99%)
Showing 10 of 20

US Market Status

Market Closed — Opens Mon (33h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access